- NCIt
- C3487
Loading cancer entity…
Loading cancer entity…
Clinical trials
96 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06376435 | A Multicentre Real-world Study of Heptapopal Ethanolamine Tablets in Concurrent/Sequential Radioimmunoinduced Thrombocytopenia | unknown | — | 500 | Hebei Medical University Fourth HospitalOTHER | 0 | Apr 19, 2024 | clinicaltrials |
| NCT03407859 | Sequential Treatment With CD20/CD22/CD10-CART After CD19-CART Treatment Base on MRD in Relapsed/Refractory B-ALL | unknown | Early Phase 1 | 100 | Zhujiang HospitalOTHER | 1 | Mar 15, 2024 |
| clinicaltrials |
| NCT01619761 | NK Cells in Cord Blood Transplantation | unknown | Phase 1 | 13 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 11, 2020 | clinicaltrials |
| NCT03777930 | The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With Megestrol | unknown | Phase 4 | 200 | Shenzhen Fifth People's HospitalOTHER | 0 | Dec 19, 2018 | clinicaltrials |
Data updated 22 days agoSource updated Apr 19, 2024source: clinicaltrials